D-0664-2021 Class I Terminated

Recalled by Ummzy, LLC — Palisades Park, NJ

FDA drug recall D-0664-2021 was initiated by Ummzy, LLC on Mar 30, 2021 and is designated Class I. Reason for recall: Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been… The recall status is terminated (terminated Jun 9, 2022). Affected quantity: 163 boxes/10 capsules per box.

Recall details

Product Type
Drugs
Report Date
Jul 28, 2021
Initiation Date
Mar 30, 2021
Termination Date
Jun 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
163 boxes/10 capsules per box

Product description

Thumbs up 7 Red 70K capsules, 10-count boxes, Distributed Ummzy LLC, Made in USA, UPC 617135894680.

Reason for recall

Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Distribution pattern

USA Nationwide

Code information

All lots within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0664-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0664-2021. Report a data issue: hello@regdatalab.com.